---  
layout: startup_page  
title: "Trace Neuroscience"  
id: "traceneuro.com"  
permalink: "/traceneurosciencetraceneuro.com11122024/"  
website: "https://www.traceneuro.com"  
funding_round: "Series A"  
funding_amount: "$101M"  
investors: "Third Rock Ventures, Atlas Venture, GV, RA Capital Management"  
about: "Trace Neuroscience is a biopharmaceutical company developing novel genomic therapies to restore UNC13A protein function in neurodegenerative diseases. Their lead program focuses on an antisense oligonucleotide for amyotrophic lateral sclerosis (ALS) to improve muscle function. The company aims to expand the promise of genomic medicine for individuals with neurodegenerative diseases."  
markets: "Biopharmaceutical, Genomic Medicine, Neurodegenerative Diseases, Biotechnology, Health Care, Life Science"  
hq: "South San Francisco, California, United States"  
founded_year: "2024"  
linkedin: "https://www.linkedin.com/company/traceneuroscience"  
twitter: "https://x.com/TraceNeuro"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/trace-neuroscience"  
pitchbook: "https://pitchbook.com/profiles/company/707911-30"  

date_display: "12-Nov-2024"  
date: "2024-11-12"

# SEO Optimization  
meta_title: "Trace Neuroscience - Series A Funding ($101M)"  
meta_description: "Trace Neuroscience, Trace Neuroscience is a biopharmaceutical company developing novel genomic therapies to restore UNC13A protein function in neurodegenerative diseases...."  
meta_keywords: "Trace Neuroscience, Biopharmaceutical, Genomic Medicine, Neurodegenerative Diseases, Biotechnology, Health Care, Life Science, Series A funding"  
canonical_url: "https://startup.projectstartups.com/traceneurosciencetraceneuro.com11122024/"  
---